---
title: AstraZeneca Vaccine Fails To Protect Against The South African Variant
date: "2021-03-17 18:09:20"
author: Forbes - Innovation
authorlink: https://www.forbes.com/sites/williamhaseltine/2021/03/17/astrazeneca-vaccine-fails-to-protect-against-the-south-african-variant/
tags:
- Forbes-Innovation
---
Two doses of the AstraZeneca Covid-19 vaccine were found to have only a 10.4% efficacy against mild-to-moderate infections caused by the B.1.351 South Africa variant, according to a phase 1b-2 clinical trial published on Tuesday in the New England Journal of Medicine.